Use App
Trending
News
Earnings
All
DIA
0.68%
SPY
0.42%
QQQ
0.18%
Trending
SPCE
10.99%
ADBE
8.25%
RKLB
2.58%
TSLA
0.77%
SATS
5.95%
SHAZ
9.69%
VELO
14.08%
TRUMP
25.14%
NASA
0.23%
ASTS
0.20%
SPCE
10.99%
ADBE
8.25%
RKLB
2.58%
TSLA
0.77%
SATS
5.95%
SHAZ
9.69%
VELO
14.08%
TRUMP
25.14%
NASA
0.23%
ASTS
0.20%
home
Symbol
JNJ
JNJ
Johnson & Johnson
$238.57
$0.24
(0.10%)
Pre-Market
Updated:
08:32 AM EDT
·
Prev Close $238.33
4
8
,
7
1
0
4
8
,
7
1
0
Earnings
Jul 15
Mkt Cap
$573.71B
Vol
46,818.00
Full Chart
Fundamentals
Mkt Cap
$573.71B
Volume
-
52W High
$251.71
52W Low
$149.04
PE Ratio
27.56
Avg. Volume
7.72M
EPS (Annual)
$11.03
P/B
7.06
Rev/Employee
$668,877.84
Earnings
Jul 15
63
Bullish Sentiment
How do you feel about JNJ?
Bullish
Bearish
Feed
News
Sentiment
Earnings
Fundamentals
Info
Advertisement
|
Remove ads.
Latest JNJ News
View
Will Skyrizi & Rinvoq Continue to Drive AbbVie's Topline Through 2026?
Zacks
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
Business Wire
IMAAVY (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies
PR Newswire
Loading...
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile